Bright Minds Biosciences Inc.

CNSX:DRUG Stock Report

Market Cap: CA$363.5m

Bright Minds Biosciences Management

Management criteria checks 2/4

Bright Minds Biosciences' CEO is Ian McDonald, appointed in May 2019, has a tenure of 5.5 years. directly owns 21.84% of the company’s shares, worth CA$79.38M. The average tenure of the management team and the board of directors is 2.3 years and 2.5 years respectively.

Key information

Ian McDonald

Chief executive officer

CA$626.2k

Total compensation

CEO salary percentagen/a
CEO tenure5.5yrs
CEO ownership21.8%
Management average tenure2.3yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Companies Like Bright Minds Biosciences (CSE:DRUG) Can Afford To Invest In Growth

Oct 16
Companies Like Bright Minds Biosciences (CSE:DRUG) Can Afford To Invest In Growth

Here's Why Bright Minds Biosciences (CSE:DRUG) Must Use Its Cash Wisely

Aug 19
Here's Why Bright Minds Biosciences (CSE:DRUG) Must Use Its Cash Wisely

We Think Bright Minds Biosciences (CSE:DRUG) Needs To Drive Business Growth Carefully

Mar 07
We Think Bright Minds Biosciences (CSE:DRUG) Needs To Drive Business Growth Carefully

We're Hopeful That Bright Minds Biosciences (CSE:DRUG) Will Use Its Cash Wisely

Nov 04
We're Hopeful That Bright Minds Biosciences (CSE:DRUG) Will Use Its Cash Wisely

CEO

Ian McDonald (35 yo)

5.5yrs

Tenure

CA$626,178

Compensation

Mr. Ian McDonald is Co-Founder of Bright Minds Biosciences Inc. and serves as its Chief Executive Officer since June 06, 2020 and serves as its President and Director since May 31, 2019. He served as Presi...

Leadership Team

NamePositionTenureCompensationOwnership
Ian McDonald
Co-Founder5.5yrsCA$626.18k21.84%
CA$ 79.4m
Ryan E. S. Cheung
Chief Financial Officer4.5yrsCA$120.00k0%
CA$ 0
Jan Pedersen
Chief Science Officer & Director2.2yrsCA$799.72kno data
Mark Smith
Chief Medical Officer1.9yrsCA$505.51kno data
Alex Vasilkevich
COO & VP of Corporate Developmentless than a yearno data0.44%
CA$ 1.6m
Emer Leahy
Consultant2.5yrsno datano data

2.3yrs

Average Tenure

57yo

Average Age

Experienced Management: DRUG's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ian McDonald
Co-Founder5.5yrsCA$626.18k21.84%
CA$ 79.4m
Jan Pedersen
Chief Science Officer & Director2.6yrsCA$799.72kno data
Robert Malenka
Member of Scientific Advisory Board2.5yrsno datano data
Herbert Meltzer
Member of Scientific Advisory Board2.5yrsno datano data
David Weiner
Independent Non-Executive Director1.8yrsCA$22.04kno data
Jeremy Fryzuk
Independent Director4.2yrsCA$7.69k4.34%
CA$ 15.8m
Nils Bottler
Independent Director4.2yrsCA$7.69k0.11%
CA$ 407.1k
Michael Bogenschutz
Member of Scientific Advisory Board2.5yrsno datano data
Peter Hendricks
Member of Scientific Advisory Board2.5yrsno datano data

2.5yrs

Average Tenure

39yo

Average Age

Experienced Board: DRUG's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.